Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Reumatol Clin (Engl Ed) ; 18(2): 91-93, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34090843

RESUMEN

OBJECTIVES: To evaluate IP-10 gene expression in patients with SLE, and its possible relationship with disease activity. PATIENTS AND METHODS: This study included 120 patients diagnosed with SLE and 30 healthy controls. The relative gene expression of IP-10 was investigated with the Fold Change method, which was correlated with the level of lupus activity evaluated with the SLEDAI 2-K instrument. RESULTS: Different levels of gene expression were found according to the SLE activity (P = <.001). IP-10 gene expression levels were higher in patients with severe activity than in those with no activity, low activity, and moderate activity. The increase in gene expression in the severe activity group was significant with a Fold Change of 3 CONCLUSION: The significant increase in relative gene expression IP-10 may be a marker of severe lupus activity.


Asunto(s)
Lupus Eritematoso Discoide , Lupus Eritematoso Sistémico , Biomarcadores , Quimiocina CXCL10/genética , Expresión Génica , Humanos , Lupus Eritematoso Sistémico/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA